A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2004
12/22/2004	EP1487811A1 N-sulfonylurea apoptosis promoters
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487791A1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487772A2 Cyclopentenone derivatives, their preparation and use in medicine
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487486A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
12/22/2004	EP1487484A2 Use of mixtures of lipopeptides for vaccine production
12/22/2004	EP1487483A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/22/2004	EP1487477A2 Methods of using flt3-ligand in immunization protocols
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487467A1 Bioactive hexane fraction from vetiveria zizanioides
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/22/2004	EP1487440A1 A use of treatment for fungal infections with a synergistic formulation of antifungal agents
12/22/2004	EP1487439A1 Solubilization of weak bases
12/22/2004	EP1487432A2 Suramin and derivatives thereof as topical microbicide and contraceptive
12/22/2004	EP1487414A2 Antibiotic composition
12/22/2004	EP1487413A1 An inhalation system for prevention and treatment of intracellular infections
12/22/2004	EP1487410A2 Preparation of sterile stabilized nanodispersions
12/22/2004	EP1487280A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
12/22/2004	EP1487273A1 Compositions and methods for treatment of microbial infections
12/22/2004	EP1487269A1 Autoinducer compounds
12/22/2004	EP1175430A4 Antisense-oligos with better stability and antisense effect
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	EP1082135B1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
12/22/2004	EP1003476B1 Prolonged release active agent dosage form adapted for gastric retention
12/22/2004	EP0906110B1 Dna vaccine formulations
12/22/2004	EP0896534B1 Injection formulations of avermectins and milbemycins based on castor oil
12/22/2004	EP0832253B9 Nucleic acid respiratory syncytial virus vaccines
12/22/2004	EP0815236B1 Haemophilus adhesion proteins
12/22/2004	CN1556857A Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
12/22/2004	CN1556856A Vaccines from infectious agents
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556797A Substituted isoxazole compound and its application as antibiotics
12/22/2004	CN1556716A Modular infusion device and method
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1556109A 2-benzene carboxylate penicillen compounds and its preparation method and application
12/22/2004	CN1556108A Extraction technology of baicalein, medicinal composition and preparation technology of medicine
12/22/2004	CN1556101A Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
12/22/2004	CN1556095A Tetracycline derivatives
12/22/2004	CN1555889A Cellar air health care therapeutic agent
12/22/2004	CN1555869A Preparation technology and use of Chinese herbal medicine phoenix-tail fern
12/22/2004	CN1555858A Chinese medicine for treating virus hepatitis and its preparation method
12/22/2004	CN1555856A Musk willow flower distillate and its preparaton method
12/22/2004	CN1555847A Medicne for preventing and treating virus and its preparaton method
12/22/2004	CN1555819A Compound for mula preparation for treating chronic hepatitis B virus and its preparation method
12/22/2004	CN1555812A Propolis drip pill and its preparation method
12/22/2004	CN1555797A Matrine oral slow release tablet and its preparation method
12/22/2004	CN1555796A Fluorokongzole powder for injection and its preparation method
12/22/2004	CN1555788A Thio pronine transfursion liquid and its preparation method
12/22/2004	CN1181087C Novel antibacterial compounds
12/22/2004	CN1181070C Urea substituted imidazoquinolines
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1181062C 2-phenoxy pyrimidine derivative and its use in treating disease
12/22/2004	CN1181057C Novel 5-pyrimidine carboxamide derivatives and pharmaceutical compositions containing said derivatives
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1180806C Pure Chinese medicine preparation for preventing and curing chicken infectious disease and its preparing process
12/22/2004	CN1180795C External use plaster for removing pus and Shengji
12/22/2004	CN1180781C Bupleurum flavone composition for resisting influenza virus and its prepn
12/22/2004	CN1180779C Sow-released roxithromycin capsule and method for preparing same
12/22/2004	CN1180776C Gel type floxacin eye ointment
12/21/2004	US6833452 Process for the preparation of highly pure crystalline (R,S)—cefuroxime axetil
12/21/2004	US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004	US6833435 Compositions isolated from bovine tissues and methods for their use
12/21/2004	US6833389 Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833363 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
12/21/2004	US6833355 Use of protein H as cytostatic agent
12/21/2004	US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin
12/21/2004	US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity
12/21/2004	US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/21/2004	CA2167926C Use of benzydamine in the treatment of pathological conditions caused by tnf
12/21/2004	CA2140649C Hybrid oligonucleotide phosphorothioates
12/16/2004	WO2004108945A2 Oligonucleotide modulation of cell adhesion
12/16/2004	WO2004108940A2 Viral genome vectors
12/16/2004	WO2004108914A1 Sars coronaviruses 3cl protease 3d-structure model and anti-sars medicines
12/16/2004	WO2004108909A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
12/16/2004	WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004	WO2004108753A1 Immunomodulating compositions, uses therefor and processes for their production
12/16/2004	WO2004108752A1 Antimicrobial polypeptides
12/16/2004	WO2004108746A2 11-12 bicyclic erythromycin derivatives
12/16/2004	WO2004108745A2 11-12 bicyclic erythromycin derivatives
12/16/2004	WO2004108733A1 Beta-lactamase inhibitor prodrug
12/16/2004	WO2004108687A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
12/16/2004	WO2004108684A1 Novel azole derivative having antifungal activity
12/16/2004	WO2004108159A2 Gb virus c (hepatitis g virus) for the treatment of hiv
12/16/2004	WO2004108156A1 A INTRACUTANEOUS INJECTION COMBINED VACCINE INCLUDED HeVac AND BCG AND ITS PREPARATION METHOD
12/16/2004	WO2004108145A1 Therapeutical composition containing dentritic cells and use thereof
12/16/2004	WO2004108134A1 Medicinal composition containing triazole compound
12/16/2004	WO2004108128A1 The use of bullatacin in manufacturing the medicaments of suppressing aids virus
12/16/2004	WO2004108125A1 Coronavirus inactivating agent
12/16/2004	WO2004108122A1 Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars)
12/16/2004	WO2004107881A1 Nutritional compositions and use thereof
12/16/2004	WO2004096822A3 Pyridyl substituted ketolide antibiotics

1 ... 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 ... 1798